• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, December 19, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

‘Flash mob’ study puts clinical decision rules for ACS to the test

Bioengineer by Bioengineer
July 10, 2019
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A nationwide flash-mob study for suspected Acute Coronary Syndrome

A novel “flash mob” study finds that, in emergency care, acute coronary syndrome cannot be safely ruled out using the Marburg Heart Score or the family physicians’ clinical assessment. In a period of only two weeks, researchers at Maastricht University collected data on 258 ACS-suspected patients by mobilizing one in five family physicians throughout the Netherlands to participate in the study. This mobilization was done by enlisting ambassadors among the FP community in the Netherlands who then spread the word through traditional professional and social networks. The study found that among 243 patients receiving a final diagnosis, 45 (18.5%) were diagnosed with acute coronary syndrome. Sensitivity for the FP rating was 86.7% and sensitivity for the MHS was 94.4%. While large, prospective studies can be time consuming and costly, this innovative “flash mob” method of research, named after the large-scale public collaborations/gatherings driven by social media, allowed for the fast investigation of one simple question on a large scale in a short timeframe.

###

A Nationwide Flash-Mob Study for Suspected Acute Coronary Syndrome

Jochen W.L. Cals, MD, PhD, et al

Maastricht University, The Netherlands

http://www.annfammed.org/content/17/4/296

Media Contact
Janelle Davis
[email protected]

Tags: CardiologyMedicine/HealthMortality/Longevity
Share12Tweet7Share2ShareShareShare1

Related Posts

Togo Nears Onchocerciasis Elimination: Vector Control, Ivermectin

December 19, 2025

CRISPR Screens Revolutionize Human Neural Organoids Research

December 19, 2025

Evaluating Daikenchuto’s Hepatobiliary Risks in Colon Cancer

December 19, 2025

New Small-Molecule Inhibitor Discovered for GMP Synthetase

December 19, 2025
Please login to join discussion

POPULAR NEWS

  • Nurses’ Views on Online Learning: Effects on Performance

    Nurses’ Views on Online Learning: Effects on Performance

    70 shares
    Share 28 Tweet 18
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    70 shares
    Share 28 Tweet 18
  • Unraveling Levofloxacin’s Impact on Brain Function

    53 shares
    Share 21 Tweet 13
  • MoCK2 Kinase Shapes Mitochondrial Dynamics in Rice Fungal Pathogen

    72 shares
    Share 29 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Togo Nears Onchocerciasis Elimination: Vector Control, Ivermectin

Revolutionizing Computing: Innovative Analogue In-Memory Tiles

CRISPR Screens Revolutionize Human Neural Organoids Research

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 70 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.